Skip to Content

C 516 (Darifenacin Hydrobromide Extended-Release 7.5 mg)

Pill with imprint C 516 is White, Round and has been identified as Darifenacin Hydrobromide Extended-Release 7.5 mg. It is supplied by Jubilant Cadista Pharmaceuticals Inc..

Darifenacin is used in the treatment of urinary frequency; overactive bladder; urinary incontinence and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Darifenacin 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C 516

Darifenacin Hydrobromide Extended-Release

Imprint
C 516
Strength
7.5 mg
Color
White
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Jubilant Cadista Pharmaceuticals Inc.
National Drug Code (NDC)
59746-0516
Inactive Ingredients
calcium phosphate dibasic anhydrous, hypromelloses, magnesium stearate, polyethylene glycol, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "C 516"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.